EUVIMEDEUVIMED entdecken
Crossref

Acidosis enables the NLRP3 inflammasome-inhibiting effects of β-hydroxybutyrate and short-chain carboxylic acids

Madeleine M Mank, Kaitlyn A Zoller, V Amanda Fastiggi, Jennifer L Ather, Matthew E Poynter iD

The Journal of Immunology · 14.05.2026 · 215 (5)

DOI: 10.1093/jimmun/vkag085 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Immunology, online erschienen am 16.05.2026. Verfasst von Madeleine M Mank und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary Disease and Critical Care, Vermont Lung Center, Department of Medicine, University of Vermont, Burlington, VT, United States. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, 3-Hydroxybutyric Acid, Inflammasomes, Carboxylic Acids. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 112 Literaturangaben. Gefördert von: University of Vermont Larner College of Medicine and Department of Medicine, U.S. National Aeronautics and Space Administration.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

NLRP3 inflammasome activation drives interleukin (IL)-1β and IL-18 cleavage and secretion and induces pyroptosis. The ketone body β-hydroxybutyrate (BHB), produced during metabolic stress such as caloric insufficiency, has been reported to inhibit this pathway. However, the conditions that enable this effect, and whether it extends to other short-chain carboxylic acids (SCCAs), are not well defined. Using adenosine triphosphate–stimulated J774 mouse macrophages and human peripheral blood mononuclear cells, we quantified IL-1β secretion to determine the pH dependence of BHB and related SCCAs in inhibiting NLRP3 activation. Both enantiomers of β-hydroxybutyric acid (BHBA) inhibited IL-1β secretion, whereas sodium β-hydroxybutyrate (NaBHB) and sodium hydroxide–neutralized BHBA did not. Acidifying NaBHB stock solutions or the treatment media, or allowing endogenous acidification during cell culture, restored NaBHB’s ability to inhibit NLRP3 activation. Several other 3- to 6-carbon SCCAs also inhibited inflammasome activation in a pH-dependent manner and prevented pyroptotic cell death. Activation of the free fatty acid receptor 3 (GPR41/FFAR3) both mimicked and enhanced the inhibitory effects of BHBA. Together, these findings demonstrate that acidic conditions enable BHB and multiple SCCAs to suppress NLRP3 inflammasome activation, partly through GPR41/FFAR3. This expands the set of metabolites that can modulate this key proinflammatory pathway during energetic stress and suggests optimized conditions for the potential therapeutic use of ketone bodies as anti-inflammatory agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NLR Family, Pyrin Domain-Containing 3 Protein3-Hydroxybutyric AcidInflammasomesCarboxylic AcidsAcidosisAnimalsMiceHumansMacrophagesInterleukin-1betaHydrogen-Ion ConcentrationLeukocytes, MononuclearCell Line

Stichwörter der Autor:innen

NLRP3 inflammasomebeta-hydroxybutyrateinflammationketone bodiesmacrophage

Substanzen

NLR Family, Pyrin Domain-Containing 3 Protein3-Hydroxybutyric AcidInflammasomesCarboxylic AcidsInterleukin-1beta

Autor:innen und Institutionen

  • Division of Pulmonary Disease and Critical Care, Vermont Lung Center, Department of Medicine, University of Vermont, Burlington, VT, United States.
  • Cellular, Molecular, and Biomedical Sciences Doctoral Program, University of Vermont, Burlington, VT, United States.

ORCID-Profile: Matthew E Poynter

Förderung

  • University of Vermont Larner College of Medicine and Department of Medicine
  • U.S. National Aeronautics and Space Administration

Zitieren

APA

Mank, M. M., Zoller, K. A., Fastiggi, V. A., Ather, J. L., & Poynter, M. E. (2026). Acidosis enables the NLRP3 inflammasome-inhibiting effects of β-hydroxybutyrate and short-chain carboxylic acids. The Journal of Immunology, 215(5). https://doi.org/10.1093/jimmun/vkag085

Vancouver

Mank MM, Zoller KA, Fastiggi VA, Ather JL, Poynter ME. Acidosis enables the NLRP3 inflammasome-inhibiting effects of β-hydroxybutyrate and short-chain carboxylic acids. The Journal of Immunology. 2026;215(5). doi:10.1093/jimmun/vkag085

BibTeX
@article{Mank2026,
  author = {Mank, Madeleine M and Zoller, Kaitlyn A and Fastiggi, V Amanda and Ather, Jennifer L and Poynter, Matthew E},
  title = {Acidosis enables the NLRP3 inflammasome-inhibiting effects of β-hydroxybutyrate and short-chain carboxylic acids},
  journal = {The Journal of Immunology},
  year = {2026},
  volume = {215},
  number = {5},
  doi = {10.1093/jimmun/vkag085}
}
Kostenlos starten →